165906830	165906830	CD	B-NP	O
|	|	NNP	I-NP	O
UM	UM	NNP	I-NP	O
|	|	VBD	B-VP	O
80659507	80659507	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4617884	4617884	CD	B-NP	O
|	|	CC	I-NP	O
10/21/2005	10/21/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/19/2005	5/19/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/3/2005	7/3/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
HOEGER	HOEGER	NN	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NNP	B-NP	O
MD	MD	NNP	I-NP	O
INTERIM	INTERIM	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Ben	Ben	NNP	B-NP	O
Manthe	Manthe	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
ATTENDING	ATTENDING	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Diego	Diego	NNP	B-NP	O
Lotton	Lotton	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Cardiology	Cardiology	NNP	B-NP	O
Gatespi	Gatespi	NNP	I-NP	O
Blvd	Blvd	NNP	I-NP	O
,	,	,	O	O
Spolavale	Spolavale	NNP	B-NP	O
,	,	,	O	O
Pennsylvania	Pennsylvania	NNP	B-NP	O
18616	18616	CD	I-NP	O
The	The	DT	B-NP	O
condition	condition	NN	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
causing	cause	VBG	B-VP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
is	be	VBZ	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
diagnoses	diagnosis	NNS	I-NP	O
include	include	VBP	B-VP	O
left	left	JJ	B-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
paresthesias	paresthesia	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fingers	finger	NNS	I-NP	O
,	,	,	O	O
benign	benign	JJ	B-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
prostatic	prostatic	JJ	B-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
,	,	,	O	O
Gleason	Gleason	NNP	B-NP	B-protein
's	's	POS	B-NP	I-protein
score	score	NN	I-NP	I-protein
2/4	2/4	CD	I-NP	I-protein
,	,	,	I-NP	O
C5-C6	C5-C6	NN	I-NP	B-DNA
and	and	CC	I-NP	O
C6-C7	C6-C7	NN	I-NP	O
disk	disk	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
nephrectomy	nephrectomy	NN	B-NP	O
for	for	IN	B-PP	O
renal	renal	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
,	,	,	O	O
hyperplastic	hyperplastic	JJ	B-NP	O
polyps	polyp	NNS	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
AICD	AICD	NN	I-NP	O
and	and	CC	O	O
dual	dual	JJ	B-NP	O
chamber	chamber	NN	I-NP	O
pacer	pacer	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
well	well	RB	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CHF	CHF	NNP	I-NP	O
Service	Service	NNP	I-NP	O
with	with	IN	B-PP	O
long-standing	long-standing	JJ	B-NP	O
New	New	NNP	I-NP	O
York	York	NNP	I-NP	O
Heart	Heart	NNP	I-NP	O
Association	Association	NNP	I-NP	O
class	class	NN	I-NP	O
3B	3B	NN	I-NP	O
idiopathic	idiopathic	JJ	I-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
night	night	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
from	from	IN	B-PP	O
8	8	CD	B-NP	O
to	to	TO	B-PP	O
9	9	CD	B-NP	O
p.m.	p.m.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
first	first	RB	B-ADVP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
An	An	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
then	then	RB	B-ADVP	O
left	leave	VBD	B-VP	O
AMA	AMA	NN	B-NP	O
without	without	IN	B-PP	O
further	further	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
after	after	IN	B-PP	O
waiting	wait	VBG	B-VP	O
four	four	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
increasing	increase	VBG	I-VP	O
cough	cough	NN	B-NP	O
with	with	IN	B-PP	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
since	since	IN	B-PP	O
5/8	5/8	CD	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
and	and	CC	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
especially	especially	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
five	five	CD	B-NP	O
times	time	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
six	six	CD	I-NP	O
months	month	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
also	also	RB	B-ADVP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
cough	cough	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
notably	notably	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
TEE-guided	TEE-guided	JJ	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
and	and	CC	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
freely	freely	RB	B-ADVP	O
admits	admit	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
claiming	claim	VBG	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
``	``	``	O	O
eating	eat	VBG	B-VP	O
like	like	IN	B-PP	O
a	a	DT	B-NP	O
horse	horse	NN	I-NP	O
''	''	''	O	O
with	with	IN	B-PP	O
meat	meat	NN	B-NP	O
and	and	CC	O	O
heavy	heavy	JJ	B-NP	O
sauces	sauce	NNS	I-NP	O
on	on	IN	B-PP	O
pasta	pasta	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
sick	sick	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
or	or	CC	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
allergies	allergy	NNS	B-NP	O
to	to	TO	B-PP	O
erythromycin	erythromycin	NN	B-NP	O
and	and	CC	I-NP	O
penicillin	penicillin	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
rash	rash	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
describes	describe	VBZ	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
contrast	contrast	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
82/62	82/62	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
HEENT	HEENT	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Carotid	Carotid	JJ	B-NP	O
upstrokes	upstroke	NNS	I-NP	O
were	be	VBD	B-VP	O
brisk	brisk	JJ	B-ADJP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
thyromegaly	thyromegaly	RB	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
and	and	CC	I-NP	O
percussion	percussion	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
did	do	VBD	B-VP	O
demonstrate	demonstrate	NN	B-NP	O
JVP	JVP	NN	I-NP	O
of	of	IN	B-PP	O
about	about	RB	B-NP	O
18	18	CD	I-NP	O
cm	cm	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
S1	S1	NN	I-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
and	and	CC	O	O
1/6	1/6	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
abdomen	abdomen	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
and	and	CC	O	O
without	without	IN	B-PP	O
pulsatile	pulsatile	JJ	B-NP	O
palpable	palpable	JJ	I-NP	O
liver	liver	NN	I-NP	O
edge	edge	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
and	and	CC	O	O
only	only	RB	B-NP	O
trace	trace	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
K	K	NN	B-NP	O
of	of	IN	B-PP	O
4.3	4.3	CD	B-NP	O
and	and	CC	O	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
136	136	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
ARB	ARB	NN	I-NP	B-protein
and	and	CC	I-NP	O
Aldactone	Aldactone	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Aggressive	Aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
for	for	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
stay	stay	NN	I-NP	O
including	include	VBG	B-PP	O
an	an	DT	B-NP	O
IV	IV	CD	I-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
later	later	RB	I-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
torsemide	torsemide	NN	I-NP	O
IV	IV	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
later	later	RB	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-VP	O
p.o.	p.o.	VB	I-VP	O
b.i.d.	b.i.d.	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
questionable	questionable	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
IV	IV	CD	I-NP	O
formation	formation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
itchiness	itchiness	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
Zaroxolyn	Zaroxolyn	NN	B-NP	B-protein
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
dopamine	dopamine	NN	B-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
later	later	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
7/20/05	7/20/05	CD	B-NP	O
for	for	IN	B-PP	O
long	long	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
that	that	IN	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
possibly	possibly	RB	B-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
sensitivity	sensitivity	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
dopamine	dopamine	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
dobutamine	dobutamine	NN	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
2/11/05	2/11/05	CD	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
dosage	dosage	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
gradually	gradually	RB	B-ADVP	O
over	over	IN	B-PP	O
8/1/05	8/1/05	CD	B-NP	O
to	to	TO	B-PP	O
1/19/05	1/19/05	CD	B-NP	O
to	to	TO	B-PP	O
rate	rate	NN	B-NP	O
about	about	IN	B-NP	O
3	3	CD	I-NP	O
mcg/kg	mcg/kg	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
dosage	dosage	NN	I-NP	O
fairly	fairly	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
repleted	replete	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
LVAD	LVAD	NN	I-NP	O
placement	placement	NN	I-NP	O
including	include	VBG	B-PP	O
PFTs	PFT	NNS	B-NP	B-protein
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
and	and	CC	I-NP	O
carotid	carotid	JJ	I-NP	O
Dopplers	Doppler	NNPS	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
significant	significant	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
contra-indication	contra-indication	NN	I-NP	O
for	for	IN	B-PP	O
LVAD	LVAD	NN	B-NP	B-protein
.	.	.	O	O

Discussion	Discussion	NN	B-NP	O
ongoing	ongoe	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
would	would	MD	B-VP	O
prefer	prefer	VB	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
LVAD	LVAD	NN	I-NP	B-protein
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
he	he	PRP	B-NP	O
were	be	VBD	B-VP	O
eligible	eligible	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
understood	understand	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
live	live	VB	I-VP	O
long	long	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
later	later	RB	I-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
send	send	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
home	home	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Hickman	Hickman	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
he	he	PRP	B-NP	O
could	could	MD	B-VP	O
receive	receive	VB	I-VP	O
home	home	NN	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
flat	flat	JJ	B-ADJP	O
and	and	CC	O	O
ischemia	ischemia	NN	B-NP	O
was	be	VBD	B-VP	O
judged	judge	VBN	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
issue	issue	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
AFib	AFib	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
asymptomatic	asymptomatic	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dopamine	dopamine	NN	I-NP	O
and	and	CC	O	O
less	less	JJR	B-NP	O
so	so	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
paced	pace	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
AICD	AICD	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
kept	keep	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	I-NP	O
digoxin	digoxin	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
nephrectomy	nephrectomy	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
monitored	monitor	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
while	while	IN	B-SBAR	O
diuresing	diurese	VBG	B-VP	O
and	and	CC	O	O
although	although	IN	B-SBAR	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
BUN	BUN	NN	I-NP	O
to	to	TO	B-PP	O
about	about	RB	B-NP	O
70	70	CD	I-NP	O
,	,	,	O	O
diuretic	diuretic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
goal	goal	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endo	Endo	UH	B-INTJ	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
diabetes	diabete	NNS	B-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
held	hold	VBD	B-VP	O
oral	oral	JJ	B-NP	O
glycemics	glycemic	NNS	I-NP	O
,	,	,	O	O
putting	put	VBG	B-VP	O
him	him	PRP	B-NP	O
on	on	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
and	and	CC	I-NP	O
NPH	NPH	NN	I-NP	B-protein
doses	dose	NNS	I-NP	I-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
low	low	JJ	B-NP	O
TSH	TSH	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
probably	probably	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
subclinical	subclinical	JJ	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
or	or	CC	O	O
sick	sick	JJ	B-NP	O
euthyroid	euthyroid	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
titrated	titrate	VBD	B-VP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
to	to	TO	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
nosebleeds	nosebleed	NNS	I-NP	O
on	on	IN	B-PP	O
10/21	10/21	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
temporarily	temporarily	RB	I-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
restarted	restart	VBD	B-VP	O
again	again	RB	B-ADVP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1.5	1.5	CD	I-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
Hickman	Hickman	NNP	B-NP	O
catheter	catheter	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
after	after	IN	B-PP	O
placement	placement	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prostate	Prostate	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
prostate	prostate	NN	B-NP	O
adenocarcinoma	adenocarcinoma	NN	I-NP	O
,	,	,	O	O
Gleason	Gleason	NN	B-NP	B-protein
2/5	2/5	CD	I-NP	I-protein
on	on	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
urologist	urologist	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
refused	refuse	VBN	I-VP	O
surgery	surgery	NN	B-NP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
PSA	PSA	NN	I-NP	B-protein
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
consult	consult	VB	I-VP	O
a	a	DT	B-NP	O
Urology	Urology	NNP	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
here	here	RB	B-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
prostate	prostate	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
consideration	consideration	NN	I-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
general	general	JJ	B-ADJP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
sitting	sit	VBG	B-VP	O
up	up	RP	B-PRT	O
and	and	CC	O	O
eating	eat	VBG	B-VP	O
his	his	PRP$	B-NP	O
food	food	NN	I-NP	O
comfortably	comfortably	RB	B-ADVP	O
as	as	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
HEENT	HEENT	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
exam	exam	NN	I-NP	O
his	his	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
about	about	IN	B-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
loud	loud	JJ	I-NP	O
P2	P2	NN	I-NP	B-DNA
and	and	CC	I-NP	O
S3	S3	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-NP	O
unchanged	unchanged	JJ	I-NP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Respiratorywise	Respiratorywise	VB	B-VP	O
his	his	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
and	and	CC	I-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
non-tensed	non-tensed	JJ	I-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

Pulses	Pulse	NNS	B-NP	O
were	be	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
radial	radial	NN	I-NP	O
and	and	CC	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
as	as	IN	B-PP	O
with	with	IN	B-PP	O
admission	admission	NN	B-NP	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
wasted	waste	VBN	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NNP	B-NP	O
Services	Service	NNPS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
for	for	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
consider	consider	VB	B-VP	O
an	an	DT	B-NP	O
ARB	ARB	NN	I-NP	B-protein
or	or	CC	I-NP	O
Aldactone	Aldactone	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
with	with	IN	B-PP	O
decreasing	decrease	VBG	B-VP	O
creatinine	creatinine	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

IV	IV	CD	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
3	3	CD	B-NP	O
mcg/kg/minute	mcg/kg/minute	NN	I-NP	O
and	and	CC	O	O
D5	D5	NN	B-NP	O
water	water	NN	I-NP	O
continue	continue	VBP	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Zaroxolyn	Zaroxolyn	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

KCl	KCl	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Glipizide	Glipizide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-5823249	0-5823249	CD	B-NP	O
CS	CS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
RATKOWSKI	RATKOWSKI	NN	B-NP	O
,	,	,	O	O
ROMAN	ROMAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KELLY	KELLY	NNP	B-NP	O
RODRIGO	RODRIGO	NNP	I-NP	O
VONDOLOSKI	VONDOLOSKI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GW77	GW77	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6618603	6618603	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/6/05	11/6/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/10/05	10/10/05	CD	B-NP	O

